​

MEI Pharma (MEIP) Stock Forecast, Price Target & Predictions

OverviewOwnershipFinancialsChart

MEIP Stock Rating

MEI Pharma stock's rating consensus is Buy, based on 16 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 10 Buy (62.50%), 6 Hold (37.50%), 0 Sell (0.00%), and 0 Strong Sell (0.00%).

Buy
Total 16 0 6 10 Strong Sell Sell Hold Buy Strong Buy

MEIP Price Target Upside V Benchmarks

TypeNameUpside
StockMEI Pharma-
SectorHealthcare Stocks 24.81%
IndustryBiotech Stocks 65.78%

Price Target Trends

1M3M12M
# Anlaysts---
Avg Price Target---
Last Closing Price$2.26$2.26$2.26
Upside/Downside---
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
May, 25--1--1
Apr, 25--1--1
Mar, 25--1--1
Feb, 25--1--1
Jan, 25--2--2
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Jul 23, 2024LaidlawHolddowngrade
Jul 22, 2024Brookline CapitalBuyHolddowngrade
Feb 08, 2023JefferiesUnderperformdowngrade
Dec 06, 2022BTIGNeutraldowngrade
Apr 12, 2022Brookline CapitalBuyBuyhold

Financial Forecast

EPS Forecast

$-15 $-11 $-7 $-3 $1 $5 Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$-10.10$-8.99$-8.80$-4.78$2.67----
Avg Forecast$-1.05$-11.18$-9.11$-5.70$3.62$-6.28$-3.71$-1.56$-1.56
High Forecast$-1.05$-11.18$-9.11$-5.70$3.62$-6.28$-3.71$-1.56$-1.56
Low Forecast$-1.05$-11.18$-9.11$-5.70$3.62$-6.28$-3.71$-1.56$-1.56
Surprise %861.90%-19.59%-3.40%-16.14%-26.24%----

Revenue Forecast

$5M $18M $31M $44M $57M $70M Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$28.91M$25.54M$40.70M$48.82M$65.30M----
Avg Forecast$48.48M$19.62M$41.79M$48.29M$65.30M$6.25M$25.00M$25.00M$25.00M
High Forecast$48.48M$19.62M$41.79M$48.29M$65.30M$6.25M$25.00M$25.00M$25.00M
Low Forecast$48.48M$19.62M$41.79M$48.29M$65.30M$6.25M$25.00M$25.00M$25.00M
Surprise %-40.36%30.15%-2.60%1.09%-----

Net Income Forecast

$-75M $-56M $-37M $-18M $1M $20M Jun 20 Jun 21 Jun 22 Jun 23 Jun 24 Jun 25 Jun 26 Jun 27 Jun 28
Jun 20Jun 21Jun 22Jun 23Jun 24Jun 25Jun 26Jun 27Jun 28
Reported$-46.02M$-50.58M$-54.74M$-31.84M$17.78M----
Avg Forecast$-22.63M$-74.43M$-60.70M$-37.95M$-46.60M$-41.84M$-24.72M$-10.39M$-10.39M
High Forecast$-16.58M$-74.43M$-60.70M$-37.95M$-34.84M$-41.84M$-24.72M$-10.39M$-10.39M
Low Forecast$-28.69M$-74.43M$-60.70M$-37.95M$-58.36M$-41.84M$-24.72M$-10.39M$-10.39M
Surprise %103.31%-32.05%-9.82%-16.10%-138.15%----

MEIP Forecast FAQ

Is MEI Pharma stock a buy?

MEI Pharma stock has a consensus rating of Buy, based on 16 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 10 Buy, 6 Hold, 0 Sell, and 0 Strong Sell, reflecting a consensus that MEI Pharma is a favorable investment for most analysts.

What is MEI Pharma's price target?

MEI Pharma's price target, set by 16 Wall Street analysts, averages - over the next 12 months. The price target range spans from - at the low end to - at the high end, suggesting a potential 0% change from the previous closing price of $2.26.

How does MEI Pharma stock forecast compare to its benchmarks?

MEI Pharma's stock forecast shows a 0% downside, underperforming the average forecast for the healthcare stocks sector (24.81%) and underperforming the biotech stocks industry (65.78%).

What is the breakdown of analyst ratings for MEI Pharma over the past three months?

  • May 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • April 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.
  • March 2025: 0% Strong Buy, 0% Buy, 100.00% Hold, 0% Sell, 0% Strong Sell.

What is MEI Pharma’s EPS forecast?

MEI Pharma's average annual EPS forecast for its fiscal year ending in June 2025 is $-6.28, marking a -335.21% decrease from the reported $2.67 in 2024. Estimates for the following years are $-3.71 in 2026, $-1.56 in 2027, and $-1.56 in 2028.

What is MEI Pharma’s revenue forecast?

MEI Pharma's average annual revenue forecast for its fiscal year ending in June 2025 is $6.25M, reflecting a -90.43% decrease from the reported $65.3M in 2024. The forecast for 2026 is $25M, followed by $25M for 2027, and $25M for 2028.

What is MEI Pharma’s net income forecast?

MEI Pharma's net income forecast for the fiscal year ending in June 2025 stands at $-41.844M, representing a -335.37% decrease from the reported $17.78M in 2024. Projections indicate $-24.72M in 2026, $-10.394M in 2027, and $-10.394M in 2028.